These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19482779)

  • 1. Physiology and endocrinology of hot flashes in prostate cancer.
    Engstrom CA; Kasper CE
    Am J Mens Health; 2007 Mar; 1(1):8-17. PubMed ID: 19482779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing hot flashes in men being treated for prostate cancer.
    Baum NH; Torti DC
    Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
    Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
    Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
    Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
    J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot flashes in prostate cancer: state of the science.
    Engstrom CA
    Am J Mens Health; 2008 Jun; 2(2):122-32. PubMed ID: 19477776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
    Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
    J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.
    Langenstroer P; Kramer B; Cutting B; Amling C; Poultan T; Lance R; Thrasher JB
    J Urol; 2005 Aug; 174(2):642-5. PubMed ID: 16006929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of hot flashes.
    Dalal S; Zhukovsky DS
    J Support Oncol; 2006; 4(7):315-20, 325. PubMed ID: 16892692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of hot flashes in prostate cancer.
    Spetz AC; Zetterlund EL; Varenhorst E; Hammar M
    J Support Oncol; 2003; 1(4):263-6, 269-70, 272-3; discussion 267-8, 271-2. PubMed ID: 15334868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hot flashes and hormonal treatment of prostate cancer].
    Lanfrey P; Mottet N; Dagues F; Bennaoum K; Costa P; Louis JF; Navratil H
    Prog Urol; 1996 Feb; 6(1):17-22. PubMed ID: 8624523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in core body temperature precede hot flashes in a prostate cancer patient.
    Hanisch LJ; Mao JJ; Gehrman PR; Vaughn DJ; Coyne JC
    Psychooncology; 2009 May; 18(5):564-7. PubMed ID: 19025973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing complications of androgen deprivation therapy for prostate cancer.
    Holzbeierlein JM
    Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation.
    Vandecasteele K; Ost P; Oosterlinck W; Fonteyne V; Neve WD; Meerleer GD
    Phytother Res; 2012 Feb; 26(2):208-13. PubMed ID: 21630361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hot flashes after orchiectomy in treatment of prostate cancer-- a serious side effect].
    Buchholz NP; Mattarelli G
    Z Gerontol; 1994; 27(5):334-6. PubMed ID: 7528960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of objective and patient-reported hot flash measures in men with prostate cancer.
    Hanisch LJ; Palmer SC; Marcus SC; Hantsoo L; Vaughn DJ; Coyne JC
    J Support Oncol; 2009; 7(4):131-5. PubMed ID: 19731578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of the side effects of androgenic deprivation].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.